[go: up one dir, main page]

NO910868L - Antiglaukompreparater inneholdende 3-arylkarbonyl-1-aminoalkyl-1h-indol og fremgangsmaate for fremstilling derav. - Google Patents

Antiglaukompreparater inneholdende 3-arylkarbonyl-1-aminoalkyl-1h-indol og fremgangsmaate for fremstilling derav.

Info

Publication number
NO910868L
NO910868L NO91910868A NO910868A NO910868L NO 910868 L NO910868 L NO 910868L NO 91910868 A NO91910868 A NO 91910868A NO 910868 A NO910868 A NO 910868A NO 910868 L NO910868 L NO 910868L
Authority
NO
Norway
Prior art keywords
aminoalkyl
compositions containing
antiglauc
indol
procedures
Prior art date
Application number
NO91910868A
Other languages
English (en)
Other versions
NO910868D0 (no
NO179612B (no
NO179612C (no
Inventor
Susan Jean Ward
Malcolm Rice Bell
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of NO910868D0 publication Critical patent/NO910868D0/no
Publication of NO910868L publication Critical patent/NO910868L/no
Publication of NO179612B publication Critical patent/NO179612B/no
Publication of NO179612C publication Critical patent/NO179612C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
NO910868A 1990-03-08 1991-03-05 Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser NO179612C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49020190A 1990-03-08 1990-03-08

Publications (4)

Publication Number Publication Date
NO910868D0 NO910868D0 (no) 1991-03-05
NO910868L true NO910868L (no) 1991-09-09
NO179612B NO179612B (no) 1996-08-05
NO179612C NO179612C (no) 1996-11-13

Family

ID=23947024

Family Applications (1)

Application Number Title Priority Date Filing Date
NO910868A NO179612C (no) 1990-03-08 1991-03-05 Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser

Country Status (21)

Country Link
EP (1) EP0445781B1 (no)
JP (1) JP3157179B2 (no)
KR (1) KR0183396B1 (no)
AT (1) ATE133663T1 (no)
AU (1) AU643757B2 (no)
CA (1) CA2036307C (no)
DE (1) DE69116705T2 (no)
DK (1) DK0445781T3 (no)
ES (1) ES2082872T3 (no)
FI (1) FI95369C (no)
GR (1) GR3019058T3 (no)
HU (1) HU215125B (no)
IE (1) IE72953B1 (no)
IL (1) IL97426A (no)
MX (1) MX174433B (no)
MY (1) MY106109A (no)
NO (1) NO179612C (no)
NZ (1) NZ237309A (no)
PH (1) PH27022A (no)
PT (1) PT96938B (no)
RU (1) RU2073670C1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2713224B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
ES2099007B1 (es) * 1993-07-16 1997-12-01 Pfizer Res & Dev Derivados de indol.
FR2714057B1 (fr) * 1993-12-17 1996-03-08 Sanofi Elf Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
ID27812A (id) * 1998-05-01 2001-04-26 Lilly Co Eli ESTER PENGHAMBAT sPLA2
ES2204067T3 (es) * 1998-05-26 2004-04-16 Pfizer Products Inc. Medicamento para el tratamiento del glaucoma y de la retinopatia isquemica.
WO2001040183A1 (en) * 1999-12-03 2001-06-07 Alcon Universal Ltd. 1-aminoalkyl-1h-indoles for treating glaucoma
AU771130B2 (en) * 2000-01-18 2004-03-11 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
WO2001058869A2 (en) * 2000-02-11 2001-08-16 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
TWI231757B (en) * 2001-09-21 2005-05-01 Solvay Pharm Bv 1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
AR038966A1 (es) * 2002-03-18 2005-02-02 Solvay Pharm Bv Derivados de tiazol que tienen actividad antagonista, agonista o agonista parcial de cb1
SE0203070D0 (en) * 2002-10-16 2002-10-16 Astrazeneca Ab Novel compounds
TW200508197A (en) * 2003-03-31 2005-03-01 Ucb Sa Indolone-acetamide derivatives, processes for preparing them and their uses
RU2376302C2 (ru) * 2004-03-05 2009-12-20 Н.В.Органон Производные (индол-3-ил)гетероциклических соединений в качестве агонистов каннабиноидных рецепторов св1
US7807707B2 (en) * 2005-03-12 2010-10-05 Conopco Inc. Hair and/or scalp care compositions incorporating amino-oxo-indole-ylidene compounds
FR2893615B1 (fr) * 2005-11-18 2008-03-07 Sanofi Aventis Sa Derives de 3-acylindole, leur preparation et leur application en therapeutique
RU2404185C1 (ru) * 2009-04-16 2010-11-20 Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН) РАВНОМЕРНО МЕЧЕННЫЙ ТРИТИЕМ (R)-(+)-[5-МЕТИЛ-3-(4-МОРФОЛИНИЛМЕТИЛ)-2,3-ДИГИДРО-[1,4]ОКСАЗИНО [2,3,4-hi]-6-ИНДОЛИЛ]-1-НАФТАЛИНИЛМЕТАНОН АЦЕТАТ
JP6025234B1 (ja) * 2016-03-10 2016-11-16 株式会社サンライフ 箸における箸置き形成方法及び箸置き機能を有する箸
CN107628981B (zh) * 2017-10-31 2019-07-30 威海市妇女儿童医院 一种肉桂酰基吲哚啉化合物及其制备青光眼药物的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1436771A (en) * 1973-02-16 1976-05-26 Labaz Indole derivatives and process for preparing the same
US4581354A (en) * 1984-08-06 1986-04-08 Sterling Drug Inc. 3-arylcarbonyl- and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles, compositions and use
US4634776A (en) * 1984-08-06 1987-01-06 Sterling Drug, Inc. 3-arylcarbonyl-and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles
US4634698A (en) * 1984-09-24 1987-01-06 Schering Corporation Antiglaucoma agents
DE3821148A1 (de) * 1988-06-23 1989-12-28 Erwin Von Dr Angerer Aminoalkylindole, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
HUT56492A (en) 1991-09-30
CA2036307C (en) 2002-07-09
DE69116705D1 (de) 1996-03-14
RU2073670C1 (ru) 1997-02-20
EP0445781A1 (en) 1991-09-11
EP0445781B1 (en) 1996-01-31
FI911131A0 (fi) 1991-03-06
JPH04235164A (ja) 1992-08-24
JP3157179B2 (ja) 2001-04-16
FI95369B (fi) 1995-10-13
NZ237309A (en) 1993-02-25
PT96938A (pt) 1991-10-31
DE69116705T2 (de) 1996-09-26
IE910700A1 (en) 1991-09-11
HU215125B (hu) 1998-09-28
KR910016745A (ko) 1991-11-05
PH27022A (en) 1993-02-01
FI911131L (fi) 1991-09-09
ES2082872T3 (es) 1996-04-01
AU643757B2 (en) 1993-11-25
CA2036307A1 (en) 1991-09-09
DK0445781T3 (da) 1996-02-19
MY106109A (en) 1995-03-31
MX174433B (es) 1994-05-16
MX24839A (es) 1993-10-01
AU7266991A (en) 1991-09-12
IL97426A (en) 1996-03-31
FI95369C (fi) 1996-01-25
IL97426A0 (en) 1992-06-21
GR3019058T3 (en) 1996-05-31
ATE133663T1 (de) 1996-02-15
NO910868D0 (no) 1991-03-05
KR0183396B1 (ko) 1999-05-01
NO179612B (no) 1996-08-05
NO179612C (no) 1996-11-13
PT96938B (pt) 1998-07-31
IE72953B1 (en) 1997-05-07

Similar Documents

Publication Publication Date Title
NO910868D0 (no) Antiglaukompreparater inneholdende 3-arylkarbonyl-1-aminoalkyl-1h-indol og fremgangsmaate for fremstilling derav.
DK0490823T3 (no)
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
DK0472327T3 (da) Præparat på form af øjendråber
HUT49113A (en) Process for producing 2-/2-hydroxy-3-phenoxy-propyl-amino/-ethyl-phenoxy-methyl-amido derivatives and pharmaceutical compositions containing them as active components
ATE60998T1 (de) Augengel sowie verfahren zu dessen herstellung.
NO872489D0 (no) Intravaginal anordning.
TR27002A (tr) Flurtamon ve diflukenikan ihtiva eden terkipler ve bunlarin yabani otlarin büyümesini kontrol altina alinmasinda kullanilmasi.
FI891473A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
IT1240683B (it) Composizione farmaceutica contenente egf
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
DE3761523D1 (de) Verfahren und zusammensetzung zur bekaempfung der vitrifikation waehrend der in-vitro-mikrovermehrung von pflanzen.
DK379387A (da) Optisk rene 1,3-dioxenoner, fremgangsmaade til fremstilling deraf og anvendelse heraf
NO903338L (no) Fremgangsmaate for mikrobiologisk fremstilling av l-carnitin.
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
DK467983D0 (da) Mikroporoes ferrosilicat og fremgangsmade til fremstilling af samme
HUT44132A (en) Herbicide compositions containing pyrazolo-(-3,4-b-)-pyridine derivatives as active components and process for producing the active components
RU1799875C (ru) Способ получени сополимеров на основе N-винилпирролидона дл м гких контактных линз
ATE60765T1 (de) Pyranderivate.
IE801737L (en) (20 s) 3ó-aminoacetamido-5ó-pregnan-20-ol

Legal Events

Date Code Title Description
MK1K Patent expired